| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |